Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$824K Sell
6,823
-596
-8% -$68.8K 0.53% 31
2025
Q4
$781K Buy
7,419
+371
+5% +$34.8K 0.47% 37
2025
Q3
$592K Buy
7,048
+275
+4% +$22.6K 0.38% 42
2025
Q2
$536K Sell
6,773
-77
-1% -$6.12K 0.39% 44
2025
Q1
$615K Buy
6,850
+12
+0.2% +$1.12K 0.63% 33
2024
Q4
$680K Buy
6,838
+181
+3% +$18.7K 0.65% 27
2024
Q3
$756K Buy
6,657
+25
+0.4% +$2.97K 0.77% 24
2024
Q2
$821K Buy
6,632
+60
+0.9% +$7.73K 0.89% 21
2024
Q1
$861K Sell
6,572
-129
-2% -$15.9K 1.03% 20
2023
Q4
$731K Buy
+6,701
New +$696K 0.95% 21

Other funds holding MRK

OneFund LLC's MRK Position: Q1 2026 in Review

OneFund LLC reduced its Merck (MRK) stake by 8% in Q1 2026, selling an estimated $68.8K and leaving 6,823 shares worth $824K. The position accounts for 0.53% of the portfolio, ranked #31.

OneFund LLC first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $861K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • OneFund LLC held 6,823 shares of Merck worth $824K as of Q1 2026.
  • OneFund LLC sold 596 Merck shares in Q1 2026, an estimated $68.8K.
  • Merck made up 0.53% of OneFund LLC's portfolio in Q1 2026, its #31 holding.
  • OneFund LLC first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • OneFund LLC's Merck position peaked at $861K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on OneFund LLC's 13F filing for Q1 2026, filed 8 May 2026.